Thilo Hackert

Prof. Dr. Thilo Hackert

Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Surgery
Verified
Journal Article
Closed access
LGLuca Gianotti
Luca Gianotti
MBMarc G. Besselink
Marc G. Besselink
MSMarta Sandini
Marta Sandini
Thilo HackertThilo Hackert
Thilo Hackert
KCKevin Conlon
Kevin Conlon
CBClaudio Bassi
Claudio Bassi

30 November 2023 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
TSThomas Frederik Stoop
Thomas Frederik Stoop
RTRutger T. Theijse
Rutger T. Theijse
LSLeonard W. F. Seelen
Leonard W. F. Seelen
BKBas Groot Koerkamp
Bas Groot Koerkamp
CECasper H. J. van Eijck
Casper H. J. van Eijck
ICInternational Collaborative Group on Locally Advanced Pancreatic Cancer
International Collaborative Group on Locally Advanced Pancreatic Cancer

27 August 2019 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
Masayuki TanakaMasayuki Tanaka
Masayuki Tanaka
AMA. L. Mihaljevic
A. L. Mihaljevic
PPPascal Probst
Pascal Probst
MHM. Heckler
M. Heckler
UKU. Klaiber
U. Klaiber
Thilo HackertThilo Hackert
Thilo Hackert

8 May 2011 in Langenbeck's Archives of Surgery
Verified
Journal Article
Closed access
PDF file
Thilo HackertThilo Hackert
Thilo Hackert
UHUlf Hinz
Ulf Hinz
SFStefan Fritz
Stefan Fritz
OSOliver Strobel
Oliver Strobel
LSLutz Schneider
Lutz Schneider
JWJens Werner
Jens Werner

17 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
VTVera Thiel
Vera Thiel
SRSimon Renders
Simon Renders
JPJasper Panten
Jasper Panten
NDNicolas Dross
Nicolas Dross
KBKatharina Bauer
Katharina Bauer
ATAndreas Trumpp
Andreas Trumpp
The peripheral nervous system (PNS) orchestrates organ function in health and disease. Most cancers, including pancreatic ductal adenocarcinoma (PDAC), are infiltrated by PNS neurons, and this contributes to the complex tumour microenvironment (TME)1,2. However, neuronal cell bodies reside in various PNS ganglia, far from the tumour mass. Thus, cancer-innervating or healthy-organ-innervating neurons are lacking in current tissue-sequencing datasets. To molecularly characterize pancreas- and PDAC-innervating neurons at single-cell resolution, we developed Trace-n-Seq. This method uses retrograde tracing of axons from tissues to their respective ganglia, followed by single-cell isolation and transcriptomic analysis. By characterizing more than 5,000 individual sympathetic and sensory neurons, with about 4,000 innervating PDAC or healthy pancreas, we reveal novel neuronal cell types and molecular networks that are distinct to the pancreas, pancreatitis, PDAC or melanoma metastasis. We integrate single-cell datasets of innervating neurons and the TME to establish a neuron–cancer–microenvironment interactome, delineate cancer-driven neuronal reprogramming and generate a pancreatic-cancer nerve signature. Pharmacological denervation induces a pro-inflammatory TME and increases the effectiveness of immune-checkpoint inhibitors. The taxane nab-paclitaxel causes intratumoral neuropathy, which attenuates PDAC growth and, in combination with sympathetic denervation, results in synergistic tumour regression. Our multi-dimensional data provide insights into the networks and functions of PDAC-innervating neurons, and support the inclusion of denervation in future therapies.

27 May 2021 in British Journal of Surgery
Verified
Journal Article
Closed access
MSM Schneider
M Schneider
Thilo HackertThilo Hackert
Thilo Hackert
OSO Strobel
O Strobel
MBM W Büchler
M W Büchler
Background: Multimodal treatment concepts enhance options for surgery in locally advanced pancreatic ductal adenocarcinoma (PDAC). This review provides an overview of technical advances to facilitate curative-intent resection in PDAC. Methods: A review of the literature addressing current technical advances in surgery for PDAC was performed, and current state-of-the-art surgical techniques summarized. Results: Artery-first and uncinate-first approaches, dissection of the anatomical triangle between the coeliac and superior mesenteric arteries and the portomesenteric vein, and radical antegrade modular pancreatosplenectomy were introduced to enhance the completeness of resection and reduce the risk of local recurrence. Elaborated techniques for resection and reconstruction of the mesenteric–portal vein axis and a venous bypass graft-first approach frequently allow resection of PDAC with venous involvement, even in patients with portal venous congestion and cavernous transformation. Arterial involvement does not preclude surgical resection per se, but may become surgically manageable with recent techniques of arterial divestment or arterial resection following neoadjuvant treatment. Conclusion: Advanced techniques of surgical resection and vessel reconstruction provide a toolkit for curative-intent surgery in borderline resectable and locally advanced PDAC. Effects of these surgical approaches on overall survival remain to be proven with high-level clinical evidence.